Cencora
Conshohocken
PA
United States
411 articles about Cencora
-
Cancer Specialists of North Florida Continues Long-Term Strategic Relationship with AmerisourceBergen
2/10/2022
AmerisourceBergen, a global healthcare solutions leader, announced that it has reached an agreement to extend its strategic relationship with Cancer Specialists of North Florida, an oncology provider with the largest cancer practice in Jacksonville, specializing in medical oncology, radiation oncology, hematology and diagnostic imaging.
-
AmerisourceBergen Reports Fiscal 2022 First Quarter Results
2/2/2022
AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 first quarter ended December 31, 2021.
-
AmerisourceBergen Releases 2021 Global Sustainability Report to Share Progress and Impact on Environmental, Social and Governance Priorities
2/1/2022
AmerisourceBergen , a global healthcare company, released its 2021 Global Sustainability Report and Environmental, Social and Governance (ESG) Reporting Index, detailing the impact of its robust sustainability and community efforts.
-
AmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene Therapies
1/25/2022
AmerisourceBergen today unveiled an integrated technology platform designed to accelerate patient access to prescribed cell and gene therapies and deliver complete visibility throughout the treatment journey.
-
AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release
1/4/2022
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2022 on Wednesday, February 2, 2022 prior to the opening of trading on the New York Stock Exchange.
-
AmerisourceBergen to Now Offer Prime Therapeutics’ IntegratedRx™ – Oncology to Eligible Hospital, Health System & Oncology Practice Customers
11/10/2021
AmerisourceBergen today announced that it is now offering Prime Therapeutics’ IntegratedRx™ – Oncology program to eligible hospital, health system and independent oncology practice customers.
-
AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
11/4/2021
AmerisourceBergen Corporation reported that in its fiscal year 2021 fourth quarter ended September 30, 2021, revenue increased 19.6 percent to $58.9 billion.
-
AmerisourceBergen & Global Pharmaceutical Manufacturers Discuss “Moving Health Forward” at Second Annual ThinkLive Trade Virtual Conference
10/21/2021
AmerisourceBergen concluded its second annual ThinkLive Trade virtual event, a three-day online summit geared toward brand, specialty, generic and consumer-product manufacturers.
-
AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2021 Earnings Release
10/5/2021
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2021 on Thursday, November 4, 2021, prior to the opening of trading on the New York Stock Exchange.
-
Teva Pharmaceuticals reached a $15 million agreement with the state of Louisiana to settle claims against the company over its marketing of opioid products.
-
AmerisourceBergen to Participate in Upcoming Investor Conferences in September 2021
9/2/2021
AmerisourceBergen Corporation announced that it will participate virtually in the following upcoming investor conferences.
-
AmerisourceBergen Adds FirstView Financial to its Suite of Manufacturer Solutions
8/19/2021
AmerisourceBergen, a global healthcare company, bolstered its suite of manufacturer solutions through the addition of FirstView Financial.
-
AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
8/18/2021
AmerisourceBergen announced the appointment of Elizabeth Campbell as Executive Vice President and Chief Legal Officer.
-
AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
8/4/2021
AmerisourceBergen Corporation reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent year-over-year to $53.4 billion.
-
Sponsored | The essential guide to drug commercialization: A manufacturer’s handbook for selectin...
7/30/2021
Learn how to unlock product potential in this step-by-step guide to making the most of your commercialization investments. -
Total payment amounts are contingent on the number of governments that will agree to suspend their lawsuits as part of the deal.
-
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
6/24/2021
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
-
AmerisourceBergen to Participate in Upcoming Investor Conferences
6/4/2021
AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate virtually in the following upcoming investor conferences: Goldman Sachs 42nd Annual Global Healthcare Conference, to be held on June 8-11, 2021; and Baird Healthcare ESG Symposium, to be held on June 17, 2021.
-
AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
6/2/2021
AmerisourceBergen Corporation announced the completion of its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses for $6.275 billion in cash, subject to a customary working capital and net debt adjustment, and 2 million shares of AmerisourceBergen common stock.
-
Anivive Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Newest Lymphoma Treatment for Dogs
5/26/2021
Strategic collaboration ensures veterinarians have rapid, easy access to LAVERDIA™-CA1 (verdinexor), the first oral tablet conditionally approved by the U.S. Food and Drug Administration (FDA) to treat lymphoma in dogs